Why EverydayMeds Offers True Price Transparency
Wegovy vs Saxenda: Complete Cost Breakdown Without Hidden Charges
When comparing Wegovy vs Saxenda online, most UK pharmacies advertise one price but charge significantly more at checkout. EverydayMeds operates differently – our published prices include everything you need. Wegovy 0.25mg costs £79.99 total (with FIRST40 code for new customers), covering your 3-minute clinical assessment, prescriber review, NHS prescription, and temperature-controlled next-day delivery. Saxenda 6mg/ml pens start at £149.99, including identical comprehensive service.
This transparent approach eliminates the frustration many patients experience when "£89 medication" becomes £154 after consultation fees, prescription charges, and delivery costs are added. Both Wegovy and Saxenda are prescription-only medicines requiring clinical oversight, but this essential service shouldn't come with surprise charges. Our GPhC-registered pharmacy (#9012878) builds trust through radical price honesty from the first click to delivery.
Wegovy vs Saxenda Pricing: Investment in Long-Term Weight Management
Understanding the true cost comparison between Wegovy vs Saxenda requires examining both medications' dosing schedules and escalation patterns. Wegovy follows a structured 16-week dose escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching 2.4mg maintenance (£209.99). Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg for £169.99) provide convenient progression through early doses.
Saxenda requires daily injections with gradual increases from 0.6mg to 3mg maintenance, making monthly costs more predictable but potentially higher annually. Both medications represent significant investments in health, which is why eliminating hidden fees matters. Code DOSE25 offers returning customer savings, while FIRST40 reduces new customer costs, with both discounts already calculated into our published prices for complete transparency.
Clinical Evidence: How Wegovy vs Saxenda Perform in Weight Management
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed 20% reduction in major cardiovascular events among participants. These results may not apply to every individual, and weight management outcomes depend on multiple factors including adherence to reduced-calorie diet and increased physical activity.
Saxenda's clinical programme showed different but meaningful results, with patients potentially achieving significant weight management when combined with lifestyle interventions. Both medications require long-term commitment, as the STEP 1 extension study indicated patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management is a long-term commitment rather than a short-term solution.
How Wegovy Works: GLP-1 Mechanism for Appetite Control
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management. This prescription-only medicine works by reducing appetite and promoting feelings of fullness after smaller meals, potentially reducing food cravings by acting on brain appetite centres. The once-weekly FlexTouch pen injection provides sustained hormone activity throughout the week, supporting consistent appetite regulation. Wegovy may help patients feel satisfied with smaller portions while reducing between-meal snacking, though individual responses vary. This mechanism requires combination with reduced-calorie diet and increased physical activity for optimal effectiveness, as the medication enhances rather than replaces healthy lifestyle choices.
Streamlined Ordering: From Assessment to Delivery
EverydayMeds simplifies the Wegovy vs Saxenda decision through our comprehensive 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our UK prescribers review applications within 3 working days (24-hour express option available), ensuring clinical suitability for either medication based on MHRA licensing and NICE guidelines. Once approved, medications ship via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for GLP-1 medication stability. Our GPhC-registered pharmacy (#9012878) handles all prescription processing, eliminating the complexity of separate prescriber and pharmacy relationships. This integrated approach ensures your chosen medication arrives safely while maintaining the same transparent pricing from consultation through delivery.
Storage and Practical Considerations: Wegovy vs Saxenda Daily Life
Wegovy offers significant practical advantages with once-weekly dosing and superior temperature stability – while both medications require refrigeration at 2-8°C before first use, Wegovy can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge. This makes travel and daily life more convenient compared to other GLP-1 medications with shorter room-temperature windows. The FlexTouch pen design provides precise dosing with clear dose escalation from 0.25mg through 2.4mg maintenance, with dose increases every 4 weeks as tolerated. Saxenda requires daily injections and more frequent pen replacements, potentially creating different lifestyle considerations. Both medications require proper disposal of used pens through pharmaceutical waste programmes, and patients should rotate injection sites to prevent lipodystrophy. Your prescriber will provide comprehensive injection training and ongoing support throughout treatment.
Why Wegovy vs Saxenda Comparison Demands Price Transparency
GLP-1 weight management medications represent long-term financial commitments, making upfront cost clarity essential for informed decision-making. Many patients comparing Wegovy vs Saxenda online abandon purchases after discovering hidden consultation fees, prescription charges, and administration costs that weren't disclosed initially. EverydayMeds eliminates this frustration by including all necessary services in our published prices, allowing genuine medication comparison without fee surprises.
This approach particularly benefits patients considering longer treatment durations, where small hidden fees compound into significant unexpected costs over months or years. Our bundle pricing provides additional value through convenience rather than hidden savings, with options like the Progress Trio (0.5mg, 1mg & 1.7mg for £369.99) ensuring uninterrupted treatment progression. Transparent pricing allows patients to focus on clinical suitability rather than fee anxiety when choosing between these important weight management options.
Start Your Weight Management Journey: Wegovy vs Saxenda Access
Both Wegovy and Saxenda are available through EverydayMeds' transparent pricing structure, with your prescriber helping determine clinical suitability based on individual health profiles and weight management goals. New customers can begin with code FIRST40, while returning customers benefit from DOSE25 savings, both applied automatically at checkout to reach our published prices. Our clinical team provides ongoing support throughout treatment, monitoring progress and adjusting approaches as needed. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and discover which medication suits your needs best. Weight management is a personal journey, and our commitment to price transparency ensures financial considerations never overshadow clinical decisions in achieving your health goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
